NAD(P)H dehydrogenase [quinone] 1 isoform d [Homo sapiens]
NAD(P)H-dependent oxidoreductase( domain architecture ID 1904052)
NAD(P)H-dependent oxidoreductase which catalyzes the reduction or oxidation of a substrate coupled to the oxidation or reduction, respectively, of a nicotinamide adenine dinucleotide cofactor NAD(P)H or NAD(P)+; similar to Escherichia coli NADPH:quinone oxidoreductase MdaB
List of domain hits
Name | Accession | Description | Interval | E-value | ||||
MdaB super family | cl43659 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
5-144 | 9.37e-20 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; The actual alignment was detected with superfamily member COG2249: Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 82.58 E-value: 9.37e-20
|
||||||||
Name | Accession | Description | Interval | E-value | ||||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
5-144 | 9.37e-20 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 82.58 E-value: 9.37e-20
|
||||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
5-101 | 3.10e-09 | ||||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 54.26 E-value: 3.10e-09
|
||||||||
Name | Accession | Description | Interval | E-value | ||||
MdaB | COG2249 | Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction ... |
5-144 | 9.37e-20 | ||||
Putative NADPH-quinone reductase (modulator of drug activity B) [General function prediction only]; Pssm-ID: 441850 [Multi-domain] Cd Length: 190 Bit Score: 82.58 E-value: 9.37e-20
|
||||||||
Flavodoxin_2 | pfam02525 | Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family ... |
5-101 | 3.10e-09 | ||||
Flavodoxin-like fold; This family consists of a domain with a flavodoxin-like fold. The family includes bacterial and eukaryotic NAD(P)H dehydrogenase (quinone) EC:1.6.99.2. These enzymes catalyze the NAD(P)H-dependent two-electron reductions of quinones and protect cells against damage by free radicals and reactive oxygen species. This enzyme uses a FAD co-factor. The equation for this reaction is:- NAD(P)H + acceptor <=> NAD(P)(+) + reduced acceptor. This enzyme is also involved in the bioactivation of prodrugs used in chemotherapy. The family also includes acyl carrier protein phosphodiesterase EC:3.1.4.14. This enzyme converts holo-ACP to apo-ACP by hydrolytic cleavage of the phosphopantetheine residue from ACP. This family is related to pfam03358 and pfam00258. Pssm-ID: 426816 [Multi-domain] Cd Length: 193 Bit Score: 54.26 E-value: 3.10e-09
|
||||||||
Blast search parameters | ||||
|